Raptor Announces Clinical Results With RP103 in Huntington's Disease Phase 2/3 Trial
February 20, 2014 07:00 ET
|
Raptor Pharmaceutical Inc
18 Month Clinical Results Showed Significantly Slower Progression of Total Motor Score in RP103 Treated Patients Without Tetrabenazine
Conference Call and Webcast Today at 8:30 a.m. EST
NOVATO,...
Raptor Pharmaceutical Corp. Provides PROCYSBI(R) Launch Update and Third Quarter 2013 Financial Results
November 07, 2013 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Nov. 7, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today provided financial results for its third quarter and nine months ended September 30, 2013.
PROCYSBI...
World Renowned Scientists and Advocates to Celebrate and Shine Light on Stem Cell Breakthroughs
October 01, 2012 08:42 ET
|
Sue & Bill Gross Stem Cell Research Center
IRVINE, CA--(Marketwire - Oct 1, 2012) - Oct. 3 marks International Stem Cell Awareness Day, a global celebration where leading scientists, researchers and supporters will acknowledge the...
Educate, Inform & Inspire Global Awareness by Sharing 'Stem Cells Offer Hope'
September 26, 2012 11:00 ET
|
Sue & Bill Gross Stem Cell Research Center
IRVINE, CA--(Marketwire - Sep 26, 2012) - Stem cell researchers are literally on the brink of developing new treatments for some of the world's most devastating diseases. Each of us is standing...